In 1968, the contamination of cooking oil by heat-degraded polychlorinated biphenyls (PCBs) caused a case of mass poisoning, the so-called Yusho incident. The cause of Yusho disease is thought to be ingested toxic substances, including not only PCBs but polychlorinated dibenzofuran (PCDFs) in Kanemi rice oil. Extensive studies have been performed since 1995 by the Yusho study group involving follow-up surveys of human blood concentrations of the casual compounds in Yusho patients as well as clinical trials of the acceleration of the excretion of these compounds in Yusho patients. We have previously measured dioxin concentrations in the blood of 649 Yusho patients in annual medical examinations from 2001 to 2009. We determined that the concentrations of 2,3,4,7,8-PeCDF 1,2,3,4,7,8-HxCDF 1,2,3,6,7,8-HxCDF, and 3,3',4,4',5,5'-HxCB (#169) in the blood of Yusho patients were more than twice as high levels to as those of normal controls. In this study, we compared the concentrations of 2,3,4,7,8-PeCDF, 1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-HxCDF, and 3,3',4,4',5,5'-HxCB (#169) in the blood of male Yusho patients with those of female Yusho patients. As a result, it was found that the mean concentrations of 2,3,4,7,8-PeCDF 1,2,3,4, 7,8-HxCDF 1,2,3,6,7,8-HxCDF, and 3,3',4,4',5,5'-HxCB (#169) in female Yusho patients were 2.9, 3.7, 2.4, and 1.3 times higher, respectively, than those of male Yusho patients.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis.
J Dermatol
December 2024
Japan Tobacco Inc, Tokyo, Japan.
Tapinarof is a nonsteroidal, topical, aryl hydrocarbon receptor agonist approved for the treatment of atopic dermatitis (AD) in Japanese patients aged ≥12 years. We evaluated the efficacy and safety of tapinarof in Japanese pediatric patients aged 2 to 11 years with AD in a phase 2, multicenter, randomized, double-blind, vehicle-controlled trial. Eligible patients (N = 121) were randomized 1:1:1 to receive tapinarof cream 0.
View Article and Find Full Text PDFTapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials.
J Dermatol
November 2024
Japan Tobacco Inc., Tokyo, Japan.
Article Synopsis
- Tapinarof cream 1% is a nonsteroidal topical treatment evaluated in two phase 3 trials for Japanese patients aged 12 and older with atopic dermatitis (AD).
- In trial ZBB4-1, tapinarof showed significantly better outcomes, with 20.24% of patients achieving clear or almost clear skin compared to 2.24% for the vehicle; ZBB4-2 demonstrated ongoing effectiveness over 52 weeks.
- Most side effects were mild to moderate, and common issues included folliculitis, acne, and headaches, indicating that tapinarof is generally safe for long-term use in treating AD.
Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials.
J Dermatol
October 2024
Japan Tobacco Inc., Tokyo, Japan.
Article Synopsis
- - Tapinarof cream (1%) was tested for treating plaque psoriasis in two phase 3 trials involving Japanese patients, showing a significant improvement in psoriasis symptoms compared to a vehicle (inactive treatment).
- - In the first trial (ZBA4-1), 20.06% of patients using tapinarof achieved high success at week 12 compared to only 2.5% with the vehicle, while in the second trial (ZBA4-2), the treatment success rate increased to 56.3% by week 52.
- - The treatment was generally safe, with most side effects being mild or moderate, such as folliculitis and contact dermatitis, confirming tapinarof cream's efficacy and safety for
Global prevalence of oral pigmentation and its related factors: a systematic review and meta-analysis.
J Stomatol Oral Maxillofac Surg
October 2022
Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address:
Background: Oral pigmentation is due to the accumulation of one or more pigments in tissues, causing changes in the color of the oral mucosal surfaces. Understanding the exact global prevalence of oral pigmentation and its associated factors helps researchers make the proper interventions at the right time; in this respect, the objective of the present systematic review and meta-analysis was to determine the global prevalence of oral pigmentation and its related factors.
Method: A systematic review and meta- analysis were conducted using the following databases: Magiran, SID, Scopus, Embase, PubMed, Web of Science (WoS), and Google Scholar.
Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
J Dermatol
December 2021
Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!